It was originally approved for treating low sexual desire, also known as hypoactive sexual desire (PT-141 libido), in premenopausal women
Download the issue brief to learn how organizations are viewing GLP-1 coverage for obesity, what to look for in a weight management point solution vendor, and more.
Analysis of integrated clinical safety data of tadalafil in patients receiving concomitant antihypertensive medications
Not all glutathione delivery methods are created equal
Semaglutide is typically administered through subcutaneous injection, a technique that allows the medication to absorb gradually into the bloodstream and effectively manage conditions such as weight management and metabolic health
In a separate double blinded placebo-controlled trial, weekly injections of Tirzepatide (15mg) in conjunction with lifestyle changes in obese patients could decrease body weight by 17.8% on average, over placebo after 72 weeks